Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Oncology Reports|May 20, 2011
pS2 protein detected by immunohistochemistry in archival primary breast cancerB Tutschek, D Niederacher, M Caminada, et al.
Oncology|January 14, 1999
Mutations and amplification of oncogenes in endometrial cancerD Niederacher, H X An, Y J Cho, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 25, 2000
DNA methylation and the mechanisms of CDKN2A inactivation in transitional cell carcinoma of the urinary bladderA R Florl, K H Franke, D Niederacher, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 16, 2004
Molecular mechanism of estrogen receptor (ER)alpha-specific, estradiol-dependent expression of the progesterone receptor (PR) B-isoformT Flötotto, D Niederacher, D Hohmann, et al.
International Journal of Cancer|April 6, 2001
Resistance to CD95-mediated apoptosis in breast cancer is not due to somatic mutation of the CD95 geneM Müschen, D Re, B Betz, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1996
INT-2 gene amplification in differentiated human thyroid cancerK M Schulte, D Niederacher, H X An, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 10, 1998
Rare loss of heterozygosity of the MTS1 and MTS2 tumor suppressor genes in differentiated human thyroid cancerK M Schulte, S Staudt, D Niederacher, et al.
Pageof 6